Digital Therapeutics for Tinnitus Market Report 2026

The digital therapeutics for tinnitus market size has grown exponentially in recent years. It will grow from $1.78 billion in 2025 to $2.27 billion in 2026 at a compound annual growth rate (CAGR) of 27.3%. The growth in the historic period can be attributed to rising incidence of hearing-related disorders, increased awareness of tinnitus management options, growth in mobile health application usage, expansion of digital audiology services, limitations of conventional tinnitus treatments.

The digital therapeutics for tinnitus market size is expected to see exponential growth in the next few years. It will grow to $5.89 billion in 2030 at a compound annual growth rate (CAGR) of 27%. The growth in the forecast period can be attributed to increasing demand for personalized auditory therapies, rising adoption of ai-driven sound optimization, expansion of remote audiology services, growing integration of digital therapeutics with hearing devices, increasing focus on long-term tinnitus symptom management. Major trends in the forecast period include increasing adoption of sound therapy applications, rising use of personalized tinnitus management programs, growing integration of ai-based audio modulation, expansion of mobile-based behavioral therapies, enhanced focus on continuous patient engagement.

The increasing adoption of digital health solutions is expected to drive the growth of the digital therapeutics for tinnitus market in the coming years. Digital health involves the use of digital technologies, connected devices, and data-driven platforms to enhance healthcare delivery, improve patient outcomes, and support health management. The adoption of digital health solutions is expanding as more individuals gain access to smartphones and the internet, allowing patients to connect with healthcare services anytime and anywhere. Digital therapeutics for tinnitus leverage this connectivity by providing mobile health apps, telemedicine platforms, and evidence-based interventions that are both accessible and convenient. For example, in December 2023, according to the National Health Service, a UK-based government agency, the number of digital health app users reached 33.6 million, up from 16.8 million in 2022, with monthly logins increasing 54% from 16.8 million to 25.8 million. As a result, the growing adoption of digital health solutions is fueling the expansion of the digital therapeutics for tinnitus market.

Major companies operating in the digital therapeutics for tinnitus market are concentrating on technological innovations, such as digital therapeutics (DTx) for neuro-behavioral disorders, to improve auditory processing and mental health outcomes. Digital therapeutics (DTx) for neuro-behavioral disorders are software-based, evidence-driven therapeutic interventions developed to prevent, manage, or treat neurological and behavioral conditions, including tinnitus, depression, or anxiety, by providing personalized digital programs that enhance cognitive, emotional, or sensory functions. For example, in February 2025, Neurive, a South Korea-based neurotechnology company, launched SoriCLEAR, a digital therapeutic aimed at addressing tinnitus and depression. Developed under the guidance of CEO Jae-Jun Song, a professor at Korea University with expertise in neuromodulation, dementia, and depression, SoriCLEAR employs artificial intelligence to evaluate factors such as age, gender, tinnitus frequency, and severity. This data-driven methodology allows the creation of personalized treatment plans tailored to each patient’s profile. SoriCLEAR has received approval from Korea's Ministry of Food and Drug Safety, making it the country’s fifth digital therapeutic for tinnitus. The platform is currently accessible in clinical settings, offering a promising non-invasive treatment option for patients with these complex conditions.

In August 2024, Neuromod Devices, an Ireland-based medical device company, collaborated with the University of South Dakota (USD) Speech, Language, and Hearing Clinic to broaden access to its Lenire bimodal neuromodulation device. Through this collaboration, it aims to increase availability of its FDA-approved Lenire bimodal neuromodulation device for tinnitus treatment. The University of South Dakota (USD) Speech, Language, and Hearing Clinic is a US-based clinical facility offering assessment and therapy services for speech, language, and hearing disorders.

Major companies operating in the digital therapeutics for tinnitus market are Sonova Holding AG, Starkey Hearing Technologies, Oticon A/S, ASKA Pharmaceutical Co. Ltd., Beltone, InfectoPharm Arzneimittel und Consilium GmbH, Signia, Oto Health Inc., Neuromod Devices Ltd., Mahana Therapeutics Inc., AudioCardio Inc., Neuromonics Inc., Treble Health Ltd., Sound Oasis LLC, AppyHapps Inc., Auricle Inc., TrueSilence Inc., MindEar Ltd., Tinnitracks, Tonal Tinnitus Therapy.

North America was the largest region in the digital therapeutics for tinnitus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics for tinnitus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital therapeutics for tinnitus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the digital therapeutics for tinnitus market by increasing costs of imported wearable audio devices, smart hearing accessories, sensors, and related electronic components used with software-based therapies. Audiology clinics and digital health providers in North America and Europe are most affected due to reliance on imported hardware, while Asia-Pacific faces cost pressures on device manufacturing. These tariffs can raise overall solution costs and slow deployment in price-sensitive markets. However, they are also encouraging local production of hearing-related devices, greater emphasis on software-only therapeutic delivery, and innovation in cost-efficient digital tinnitus management solutions.

The digital therapeutics for tinnitus market research report is one of a series of new reports that provides digital therapeutics for tinnitus market statistics, including digital therapeutics for tinnitus industry global market size, regional shares, competitors with a digital therapeutics for tinnitus market share, detailed digital therapeutics for tinnitus market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics for tinnitus industry. This digital therapeutics for tinnitus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital therapeutics for tinnitus are evidence-based digital interventions created to reduce or manage the experience of tinnitus through software-based therapies. These solutions utilize technologies such as mobile applications, artificial intelligence, and data analytics to provide personalized sound therapy and behavioral support. They seek to enhance auditory health and overall well-being through ongoing digital engagement and clinically validated therapeutic methods.

The main product types of digital therapeutics for tinnitus include software applications, devices, and services. Software applications are clinically validated programs designed to deliver therapeutic interventions for managing tinnitus symptoms and enhancing auditory health. These solutions employ therapies such as cognitive behavioral therapy, sound therapy, educational therapy, and others, and are made available through online platforms, hospitals and clinics, and other channels. The primary end users are adults, children, and older adults.

The digital therapeutics for the tinnitus market consist of revenues earned by entities by providing services such as remote therapy monitoring, teleconsultation support, data analytics and reporting services, patient engagement and coaching programmes and subscription-based therapy management. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for the tinnitus market include sales of wearable sound generators, smart headbands and earbuds, AI-powered therapy platforms, neurostimulation devices and virtual reality (VR) therapy systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.